EudraCT Number:          2015-001314-10Sponsor Protocol Number: EFC14280Sponsor Name:            SANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENTFull Title:              A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients with Bilateral Nasal Polyposis on a Background Therapy with Intranasal CorticosteroidsStart Date:              2016-11-29Medical condition:       Bilateral nasal polyposisDisease:                 Version: 19.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10028756, Term: Nasal polyps, Level: PTPopulation Age:          Adults, ElderlyGender:                  Male, FemaleTrial protocol:          SE(Completed) PT(Completed) ES(Completed) BE(Completed) Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-001314-10